Analyst Ratings for Trevi Therapeutics (TRVI)
TRVI Rating Summary
TRVI Price Target Summary
- Highest: $40.00 (Raymond James)
- Lowest: $20.00 (Morgan Stanley)
- Average: $29.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.33 (+146.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$29.33 (+146.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | BMO Capital » Updated 10/7/2026 |
Connor Murphy | New Coverage | Outperform (N/A) |
36.00 (N/A) |
19.07 (11.88) |
-37.7% | Details |
| 11/13/2025 | Leerink » Updated 4/21/2026 |
Roanna Ruiz | New Coverage | Outperform (N/A) |
25.00 (21.00) |
11.85 (11.88) |
0.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
